A citation-based method for searching scientific literature

J Mazieres, C Cropet, L Montané, F Barlesi, P J Souquet, X Quantin, C Dubos-Arvis, J Otto, L Favier, V Avrillon, J Cadranel, D Moro-Sibilot, I Monnet, V Westeel, J Le Treut, E Brain, J Trédaniel, M Jaffro, S Collot, G R Ferretti, C Tiffon, C Mahier-Ait Oukhatar, J Y Blay. Ann Oncol 2020
Times Cited: 59

Benjamin J Solomon, Tony Mok, Dong-Wan Kim, Yi-Long Wu, Kazuhiko Nakagawa, Tarek Mekhail, Enriqueta Felip, Federico Cappuzzo, Jolanda Paolini, Tiziana Usari, Shrividya Iyer, Arlene Reisman, Keith D Wilner, Jennifer Tursi, Fiona Blackhall. N Engl J Med 2014
Times Cited: 2019

List of shared articles

Times cited

Recent advances in lung cancer genomics: Application in targeted therapy.
Neha Pathak, Sindhura Chitikela, Prabhat Singh Malik. Adv Genet 2021

Expression and Prognostic Significance of c-Myc, ALK, ROS1, BRAF, and PD-L1 Among Patients With Non-Small Cell Lung Cancer.
Patrapim Sunpaweravong, Patcharaporn Thongwatchara, Rassamee Chotipanvithayakul, Surasak Sangkhathat, Paramee Thongsuksai. Clin Med Insights Oncol 2022

A pharmacological exploration of targeted drug therapy in non-small cell lung cancer.
Ajay P Jayan, K R Anandu, Krishnadas Madhu, V N Saiprabha. Med Oncol 2022

Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer.
Joel Rivera-Concepcion, Dipesh Uprety, Alex A Adjei. Cancer Res Treat 2022

Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology Report.
Konstantinos Christofyllakis, Ana Raquel Monteiro, Onur Cetin, Igor Age Kos, Alastair Greystoke, Andrea Luciani. J Geriatr Oncol 2022

First line Immunotherapy for Non-Small Cell Lung Cancer.
Nicola J Nasser, Miguel Gorenberg, Abed Agbarya. Pharmaceuticals (Basel) 2020

Prevalence of highly actionable mutations among Indian patients with advanced non-small cell lung cancer: A systematic review and meta-analysis.
Ruchir Raman, Varun Ramamohan, Anurag Rathore, Deepali Jain, Anant Mohan, Vishal Vashistha. Asia Pac J Clin Oncol 2022

Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Alessandro De Toma, Giuseppe Lo Russo, Diego Signorelli, Filippo Pagani, Giovanni Randon, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Monica Ganzinelli,[...]. Crit Rev Oncol Hematol 2021

The Value of Population Screening in Advancing Personalized Medicine in the Field of Lung Cancer.
Alice Mogenet, Laurent Greillier, Pascale Tomasini. Pharmgenomics Pers Med 2021

Targeting molecular alterations in non-small-cell lung cancer: what's next?
Rafael López-Castro, Tania García-Peña, Xabier Mielgo-Rubio, Mariona Riudavets, Cristina Teixidó, Noelia Vilariño, Felipe Couñago, Laura Mezquita. Per Med 2022

BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy.
Marcel Wiesweg, Cedric Preuß, Julia Roeper, Martin Metzenmacher, Wilfried Eberhardt, Ursula Stropiep, Katrin Wedeken, Henning Reis, Thomas Herold, Kaid Darwiche,[...]. Eur J Cancer 2021